GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
13.22
+0.72 (5.76%)
At close: Sep 18, 2025, 4:00 PM EDT
13.64
+0.42 (3.18%)
After-hours: Sep 18, 2025, 5:22 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $820.03 million as of September 18, 2025. Its market cap has increased by 60.67% in one year.
Market Cap
820.03M
Enterprise Value
511.99M
1-Year Change
60.67%
Ranking
Category
Stock Price
$13.22
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $820.03M, an increase of 1.45%. That is a compound annual growth rate of 0.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2025 | 820.03M | 125.16% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.85B |
| Johnson & Johnson | 427.00B |
| AbbVie | 389.81B |
| UnitedHealth Group | 308.46B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 232.28B |